Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of DOT Spectacles in Chinese Children

NCT: NCT05562622 · ACTIVE_NOT_RECRUITING

NCT IDNCT05562622
StatusACTIVE_NOT_RECRUITING
Start Date2023-02-05
Completion2027-12-31
SponsorSightGlass Vision, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of myopia in children of Chinese origin.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑